Table 3 Univariate and multivariate analysis of factors influencing stone recurrence after ESWL treatment

2 weeks post- ESWL

 αGST

4.58

0 0.99–21.12

0.051

 πGST

4.40

0.98–19.85

0.054

 AP _CaOx

4.58

0.99–21.12

0.051

 MDA

3.54

0.78–16.03

0.102

 HA

3.33

0.76–14.58

0.110

 NPC

0.52

0.12–2.17

0.368

 NRP

3.33

0.76–14.58

0.110

 SLC26A6

4.58

0.99–21.12

0.051

 CXCR4

4.40

0.98–19.85

0.054

 MMP2

3.3

0.75–14.47

0.113

 MMP9

4.4

0.98–19.85

0.054

 OPN

6.05

1.27–28.73

0.024*

18.61

0.81–426.9

0.067

 THP

0.86

0.21–3.58

0.833

4 weeks post-ESWL

 αGST

0.89

0.22–3.67

0.870

 πGST

0.52

0.12–2.17

0.368

 AP _CaOx

60.7

2.58–659.3

0.023*

36.53

1.81–737.4

0.019*

 MDA

1.56

0.36–6.69

0.553

 HA

0.89

0.22–3.67

0.870

 NPC

1.50

0.36–6.23

0.577

 NRP

2.50

0.59–10.62

0.214

 SLC26A6

5.14

1.03–25.60

0.046

3.33

0.27–41.92

0.352

 CXCR4

6.05

1.27–28.73

0.024

6.81

0.41–115.7

0.184

 MMP2

0.88

0.21–3.59

0.853

 MMP9

0.88

0.21–3.59

0.853

 OPN

8.67

1.66–45.21

0.010*

13.55

1.75–243.5

0.047*

 THP

2.57

0.60–11.06

0.204